NT_1170x120_1-11-18

Parata Systems goes live with new website

Print Friendly, PDF & Email
DURHAM, N.C. — Parata Systems has launched a new website that the company said offers a more user-friendly experience.

Parata new website_April 2015_featured

The new Parata.com sports a fresh look and provides improved navigation and functionality across today’s browsers and mobile devices.

The pharmacy automation and medication management solution provider said Tuesday that the new Parata.com provides improved navigation and functionality across today’s browsers and mobile devices, making it easier for pharmacists to learn about Parata’s solutions, browse the resource library, access their customer accounts and order supplies online.

“This website redesign is part of our ongoing commitment to providing tools and solutions that impact pharmacies’ bottom lines,” stated Parata chief executive officer DJ Dougherty. “As the health care industry continues to become more digital, progressive pharmacists are incorporating mobile technology to better serve patients. With this new site, we can put the tools, resources and information our customers need right at their fingertips.”

The new sites presents product information, videos and technical specifications in fresh formats as well as features case studies and detailed resources from leading Parata pharmacies. In addition, Parata.com makes it easier for visitors to stay updated on news and events and share helpful pages and resources with friends and colleagues across Facebook, Google+, LinkedIn and Twitter.

“Parata has always sought opportunities to connect like-minded pharmacists,” commented Mark Longley, executive vice president of sales and business development. “Our revamped website makes it easy for pharmacists to access relevant, timely content on how their colleagues are maximizing Parata technology to ensure safety and efficiency, improve adherence and outcomes, and grow their businesses by attracting patients and partners.”


NT_728x90_10-3-18

TRP_728x90_12-19-19

Comments are closed.